Healthcare & Life Sciences

SERB Specialty Pharmaceuticals

France
Sign in to unlock

About

SERB Specialty Pharmaceuticals develops, acquires, and markets prescription medicines targeting rare and life-threatening diseases. It operates directly in Europe, the Middle East, and Australia, and distributes its products globally through a network covering over 80 countries.

Explore SERB Specialty Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing